Rate This Blog
 0 rating(s)
Categories
Archives
• Current Entries
• August 2009 • June 2009 • May 2009 • March 2009 • February 2009 • November 2008 • October 2008
Latest Entries
Loading...
 |
Kevin's Advocacy Blog
A blog to explore prostate cancer public policy initiatives and strategies.
ELECTION 2008: The Congressional Races
Posted by:
KevinatZERO on
November 4, 2008 at
11:51AM UEDT
Who Are We Watching?
The expectation today is that sweeping changes will be made to the Congressional landscape, and here is a primer for key Senate and Congressional races to watch for as the results start to trickle in this evening. In Alaska, prostate cancer survivor Senator Ted Stevens faces an uphill battle after being convicted of 7 felony charges of filing false disclosure statements. Stevens is the ranking member of the Senate Defense Appropriation Subcommittee. Senator Wayne Allard (CO) is retiring and will likely be replaced by current Rep. Mark Udall (CO02) who has supported research funding for prostate cancer in the past. Marilyn Musgrave (CO04) another past supporter for research funding trails in the polls to challenger Betsy Markey. Tim Mahoney (FL16) and Lincoln Diaz-Balart (FL21) are both supporters for prostate cancer research and also both on the endangered list. Florida has been a state where support from the delegation has been hard to win, so losing 2 there would be a hard loss to take. Additionally, we’re losing key support on the House Appropriations Committee in Dr. Dave Weldon (FL15) – probable replacement State Senator Bill Posey is at least familiar with prostate cancer issues having chaired the committee with jurisdiction over the prostate cancer insurance mandate bill before the Florida legislature last year. Jim Marshall (GA08) is a key leader for prostate cancer in the House as original sponsor of the Thomas J. Manton Early Detection and Treatment Act and a supporter for research funding. He currently holds a slim lead in the polls, but is a target in a district that voted 61% for Bush and will likely garner higher numbers for McCain. Senator Saxby Chambliss supports prostate cancer issues and holds a slim lead in the polls against challenger Jim Martin. Elizabeth Dole, who has been an ally in the Senate on prostate cancer issues and whose husband former Senator Bob Dole is a prostate cancer survivor, trails in most polls to newcomer Kay Hagen. Vito Fosella (NY13), Michael McNulty (NY21), James Walsh (NY25), and Thomas Reynolds (NY26) are all leaving office for various reasons which takes 4 solid prostate cancer supporters off of our list and leaves us with unknown levels of support in the coming year. John Murtha (PA12), chairman of the House Defense Appropriations Subcommittee, leads holds a narrow lead in the polls after making disparaging remarks about his district on television recently. Christopher Carney (PA10) is the Democratic-incumbent in a strong Republican district. He supports funding for prostate cancer research. Phil English (PA03) is past supporter for research funding trails in the polls to Democratic challenger Kathleen Ann "Kathy" Dahlkemper. In Virginia, retiring Senator John Warner, a supporter of prostate cancer research funding, will likely be succeeded by former Governor Mark Warner (no relation). While then-Gov. Warner signed a proclamation designating September as Prostate Cancer Awareness Month in Virginia, like other newcomers he will be an unknown initially. Tom Davis’ (VA11) retirement leaves another hole that will likely be filled by Democrat candidate Gerry Connelly. Other key races we’re watching today include: Jon Porter (NV03) Nancy Boyda (KS02) Carol Shea-Porter (NH01) Christopher Shays (CT04) Henry Brown (SC01) John Yarmuth (KY03) Read AWARE tomorrow for a report on today’s results on these and other key races.
Send This | Categories: Advocacy, Congress, Election 2008
(2) Comments
|
 |
ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health service provider. If you have problems with the site or need more information, please call us at 1.888.245.9455 or e-mail your comments. All names, logos and articles are the copyrights of the respective owners.
